Login to Your Account



Pharma: Other News To Note


Thursday, June 7, 2012

• Merck Serono SA, of Geneva, said it is taking its first step into the biosimilar space through a partnership with Dr. Reddy's Laboratories Ltd., of Hyderabad, India. The partnership will focus on co-developing a portfolio of biosimilar cancer compounds, most of which will be monoclonal antibodies. The agreement, based on full R&D cost-sharing, covers co-development, manufacturing and commercialization of the compounds.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription